What it is
KLOW is a fixed 80 mg community blend containing GHK-Cu, KPV, BPC-157, and TB-500. The ingredients have their own research histories, but the blend itself does not have a validated protocol.
Evidence boundary
Fixed-ratio community blend. The individual components have separate research histories, but the KLOW combination itself does not have a trial establishing an optimal dose.
Trial evidence
- PMID 42578445 — Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
- PMID 42578445 — Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
- PMID 42533460 — [title not reviewed here; PubMed hit rate-limited during the last pass].
Preparation and measurement
Reconstitution: 80 mg vial + 3 mL BAC = 26.67 mg/mL.
Concentration matches.
Reference schedule
| Phase | Dose | Draw / measure | Frequency | Weekly total |
|---|---|---|---|---|
| Week 1 loading | 2.67 mg total per draw | 10 U (0.10 mL) | Twice daily | 37.3 mg total/week |
| Weeks 2–8 | 2.67 mg total per draw | 10 U (0.10 mL) | Once daily | 18.7 mg total/week |
| Break | 0 | No draw | Off | 0 |
Week 1 loading
- Dose
- 2.67 mg total per draw
- Draw / measure
- 10 U (0.10 mL)
- Frequency
- Twice daily
- Weekly total
- 37.3 mg total/week
Weeks 2–8
- Dose
- 2.67 mg total per draw
- Draw / measure
- 10 U (0.10 mL)
- Frequency
- Once daily
- Weekly total
- 18.7 mg total/week
Break
- Dose
- 0
- Draw / measure
- No draw
- Frequency
- Off
- Weekly total
- 0
Weekly totals apply only during the active phase.
Titration rules
- The collected KLOW convention changes frequency, not draw size: 10 U twice daily during week 1, then 10 U once daily.
- Do not add standalone GHK-Cu at full dose during the KLOW block; the blend already supplies 1.67 mg per 10 U draw.
Cycle length and breaks
Use a defined 8-week block, then stop for at least 4 weeks before reassessment.
What to monitor
- Injection-site irritation or burning
- Changes in pain, range of motion, swelling, skin response, and gut symptoms
- Whether any separate GHK-Cu product is being added on top of the blend
Practical rules
- Keep timing, route, concentration, and observation notes consistent if you are comparing notes.
- Do not add standalone GHK-Cu at full dose during the KLOW block.
- Recalculate totals before combining it with any other peptide.
Related protocols
GLOW Blend (70 mg) Peptide Protocol & DosingTri-Heal Blend (45 mg) Peptide Protocol & DosingKPV Peptide Protocol & DosingBPC-157 Peptide Protocol & Dosing Supply & lot verification
Availability and batch-linked COA records for KLOW Blend (80 mg) Peptide Protocol & Dosing are kept with the current product listing.
View availability & COA → Verification notes